Steven S. Rosenfeld, MD, PhD, Neurologist, Department of Cancer Biology, Cleveland Clinic
Using North Carolina HCUP administrative data to examine women’s rates of premenopausal surgeries in inpatient and outpatient settings, 1997-2013
Kanta Subbarao, MPH, NIH/NIAID
Stephen Young, MD, Professor of Medicine, Director of UCLA Cellular & Molecular Cardiology Unit, UCLA
David Lanfear, MD, MS, Section Head, Advanced Heart Failure and Cardiac Transplantation, Henry Ford Heart and Vascular Institute, Director, Advanced Heart Failure Fellowship Program, Research Scientist, Center for Health Services Research, Associate Professor of Medicine, Wayne State University
Alexei A. Bogdanov, PhD, Professor, Department of Radiology, University of Massachusetts Medical School. Hosted by the UNC Center for Nanotechnology in Drug Delivery and the Carolina Center of Cancer Nanotechnology Excellence.
Tammy Triglianos, RN, MS, APRN-BC, AOCNP
Michael Fischbach, USCF
Lieping Chen, MD, PhD, United Technologies Chair in Cancer Research, Professor of Immunobiology, Dermatology and Medicine, Director of Cancer Immunology Program, Yale Cancer Center, Yale School of Medicine
The 9th Chapel Hill Pharmaceutical Sciences Conference will be held at the Carolina Club, Chapel Hill on Thursday, October 15. The theme of the Conference is Frontiers in Chemical Biology: Transforming Drug Discovery. Featured speakers include Kevan Shokat (UCSF), Tom Muir (Princeton), Donald McDonnell (Duke), Bryan Roth (UNC), Stephen Fesik (Vanderbilt), Brian Shoichet (UCSF), Stephen Frye (UNC) and Tom Kodadek (Scripps). The registration is free, but is required by September 30 to attend the Conference. There is also a poster session at the Conference, and all posters are eligible for competition of poster awards. Students and postdoctoral fellows are highly encouraged to submit poster abstracts.